Disclaimer:

Disclaimer: The blog posts and comments on this blog and posts on social networks are not investment recommendation, are provided solely for informational purposes, and do not constitute an offer or solicitation to buy or sell any securities. The opinions expressed on the blog are Petar Posledovich's. Petar Posledovich does not guarantee the accuracy of the information presented on this blog and social networks. The information presented is "as is". The blog is stocks analysis and valuation, Bitcoin, Cryptocurrencies, Artificial Intelligence, AI, deep-learning focused. Independent, unbiased AI insights. Petar Vladimirov Posledovich is not liable for any investment losses incurred by reading and interpreting blog posts on this blog and posts on social networks. Conflicts of interest: I may possess some of the securities, currencies or their derivatives mentioned in the blog post and posts on social networks! The blog is property of Wolfteam Ltd. www.wolfteamedge.com Respectfully yours, Petar Posledovich

Tuesday, September 20, 2022

Bavarian Nordic, Moderna Valuation


Bavarian Nordic, the only approved monkeypox vaccine producer is undervalued. So is Moderna, the Covid, coronavirus vaccine producer. Big time.

Bavarian Nordic's market capitalzation can rise 17 times from the current level.

Moderna, with its messenger RNA technology is more a long-term play on the future of healthcare and biotechnology and its market capitalisation  can rise 7 times from current levels in 10-12 years.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)